Outset Medical (OM) Capital Expenditures Growth (3y) (2022 - 2026)
Outset Medical (OM) Capital Expenditures Growth (3y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.10 Bn | 176.81 Bn | 6.27 Bn | 1.64% |
| 2 | Stryker | 128.79 Bn | 125.91 Bn | 3.81 Bn | 8.49% |
| 3 | Medtronic | 108.97 Bn | 99.75 Bn | 6.41 Bn | 8.89% |
| 4 | Boston Scientific | 68.57 Bn | 67.12 Bn | 3.61 Bn | 16.83% |
| 5 | Edwards Lifesciences | 47.64 Bn | 43.97 Bn | 1.29 Bn | 1.81% |
| 6 | GE HealthCare Technologies | 28.40 Bn | 26.11 Bn | 1.98 Bn | 7.57% |
| 7 | Dexcom | 28.32 Bn | 27.20 Bn | 750.30 Mn | 0.84% |
| 8 | Smith & Nephew | 26.94 Bn | 26.36 Bn | - | - |
| 9 | Koninklijke Philips | 25.45 Bn | 22.33 Bn | 2.07 Bn | 2.15% |
| 10 | Outset Medical | 78,728.30 | -286.57 Mn | 12.10 Mn | -56.87% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -56.87% |
| Dec 31, 2025 | 37.03% |
| Sep 30, 2025 | 29.31% |
| Jun 30, 2025 | -26.22% |
| Mar 31, 2025 | -56.34% |
| Dec 31, 2024 | -43.98% |
| Sep 30, 2024 | -43.28% |
| Jun 30, 2024 | 36.23% |
| Mar 31, 2024 | -65.73% |
| Dec 31, 2023 | 28.61% |
| Sep 30, 2023 | -18.77% |
| Jun 30, 2023 | -28.64% |
| Mar 31, 2023 | -33.86% |
| Dec 31, 2022 | 41.03% |